Related Experiment Video
Updated: Apr 21, 2026
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
16.1K
Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides
Marta Marzullo1,2, Assia De Simone1, Marta Terribili1
1Department of Biology and Biotechnologies 'C. Darwin', Sapienza University of Rome, 00185 Rome, Italy.
Disease Models & Mechanisms
|April 20, 2026
Summary
Myotonic dystrophy type 2 (DM2) toxic proteins, polyQAGR and polyLPAC, disrupt cellular functions like nucleolar integrity and autophagy. These distinct toxic effects contribute to DM2 pathogenesis and offer potential therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Neuroscience
Background:
- Myotonic dystrophy type 2 (DM2) is a genetic disorder caused by expanded CCTG repeats in the CNBP gene.
- Repeat-associated non-AUG (RAN) translation produces toxic proteins, polyQAGR and polyLPAC, in DM2.
Purpose of the Study:
- To investigate the distinct roles of polyQAGR and polyLPAC in DM2 pathogenesis.
- To identify potential therapeutic targets for DM2.
Main Methods:
- Expressed codon-optimized polyQAGR and polyLPAC in Drosophila melanogaster.
- Analyzed effects on viability, lifespan, eye degeneration, and locomotor activity.
- Assessed nucleolar integrity, rRNA processing, and autophagy pathways.
- Investigated polyLPAC effects in human cells and DM2 patient myoblasts.
Main Results:
- Both polyQAGR and polyLPAC reduced fly viability and lifespan, causing eye and locomotor defects.
- PolyQAGR accumulated in the nucleolus, disrupted rRNA processing, and impaired autophagy.
- PolyLPAC increased cytoplasmic TIAR levels in human cells and DM2 myoblasts.
- Autophagy modulation affected polyQAGR-induced toxicity.
Conclusions:
- PolyQAGR and polyLPAC exhibit distinct toxic mechanisms contributing to DM2.
- These proteins represent promising therapeutic targets for myotonic dystrophy type 2.
